The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects

被引:0
作者
Masaomi Takizawa
Dirk Cerneus
Ingrid Michon
Sanne Rijnders
Desiree van der Heide
John Meijer
Matthias Stoelzel
Yuichiro Sato
机构
[1] Astellas Pharma Inc.,
[2] Astellas Pharma Europe B. V.,undefined
[3] Astellas Pharma Inc.,undefined
来源
Advances in Therapy | 2020年 / 37卷
关键词
Anandamide; Fatty acid amide hydrolase; First-in-human study; Pharmacokinetics; Safety; Tolerability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3878 / 3900
页数:22
相关论文
共 44 条
  • [41] Houbiers JGA(undefined)undefined undefined undefined undefined-undefined
  • [42] Takizawa M(undefined)undefined undefined undefined undefined-undefined
  • [43] Hatta T(undefined)undefined undefined undefined undefined-undefined
  • [44] Iitsuka H(undefined)undefined undefined undefined undefined-undefined